Catalent, Inc. Profile Avatar - Palmy Investing

Catalent, Inc.

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Techno…
Drug Manufacturers - Specialty & Generic
US, Somerset [HQ]

Balance Sheet

14 Sheets · Starting from None
In Million USD. Margins, Growth Rates In %
Metric 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 None
Assets
- - 3,139.00 3,056.00 3,090.00 3,145.00 3,091.00 3,454.00 4,531.00 6,184.00 7,776.00 9,112.00 10,507.00 10,782.00 - -
Current
- - 704.00 677.00 687.00 737.00 790.00 1,059.00 1,240.00 1,395.00 2,293.00 2,918.00 2,916.00 2,679.00 - -
Non Current
- - 2,434.00 2,378.00 2,402.00 2,407.00 2,300.00 2,394.00 3,290.00 4,788.00 5,483.00 6,194.00 7,591.00 8,103.00 - -
Liabilities
- - 3,489.00 3,467.00 3,462.00 2,511.00 2,455.00 2,730.00 3,444.00 4,502.00 4,877.00 5,197.00 5,712.00 6,147.00 - -
Current
- - 439.00 410.00 453.00 399.00 391.00 469.00 576.00 670.00 893.00 1,196.00 1,072.00 1,507.00 - -
Non Current
- - 3,050.00 3,056.00 3,009.00 2,112.00 2,064.00 2,261.00 2,867.00 3,831.00 3,984.00 4,001.00 4,640.00 4,640.00 - -
Equity
- - -350.00 -410.00 -371.00 634.00 635.00 723.00 1,086.00 1,681.00 2,898.00 3,915.00 4,795.00 4,635.00 - -
Stockholders' Equity
- - -350.00 -410.00 -371.00 634.00 635.00 723.00 1,086.00 1,681.00 2,898.00 3,915.00 4,795.00 4,635.00 - -
Retained Earnings
- - -1,382.00 -1,428.00 -1,379.00 -1,166.00 -1,036.00 -955.00 -872.00 -723.00 -535.00 25.00 538.00 262.00 - -
Common Stock
- - - - - - - - 1.00 1.00 1.00 1.00 1.00 1.00 2.00 2.00 2.00 - -
Preferred Stock
- - - - - - - - - - - - - - - - 606.00 606.00 359.00 10,507.00 24.00 - -
Profit
-54.00 -24.00 -46.00 16.00 212.00 111.00 109.00 83.00 137.00 173.00 585.00 499.00 -232.00 - -
Dividends
- - - - - - - - - - - - - - - - - - -36.00 -22.00 -4.00 - - - -
Minority Interest
- - - - - - - - 5.00 3,091.00 3,454.00 - - - - - - - - - - - - - -
Other Stockholders' Equity
- - 1,023.00 1,026.00 1,031.00 1,973.00 1,976.00 1,992.00 2,283.00 2,150.00 3,212.00 3,846.00 -5,858.00 4,701.00 - -
Loss Other Compr. Income
- - 7.00 -9.00 -24.00 -174.00 -305.00 -314.00 -325.00 -353.00 -386.00 -317.00 -394.00 -354.00 - -
End of CTLT's Analysis
CIK: 1596783 CUSIP: 148806102 ISIN: US1488061029 LEI: - UEI: -
Secondary Listings
CTLT has no secondary listings inside our databases.